FDA Approves Forest Laboratories' Bystolic to Lower Hypertension

Bystolic is in a group of drugs called beta-blockers.

Beta-blockers affect the heart and circulation (blood flow through arteries and veins).

Bystolic is used to treat hypertension (high blood pressure). It works by slowing down the heart and decreasing the amount of blood it pumps out. This helps to decrease blood pressure.

This drug belongs to a class of medications called beta blockers. It works by preventing a certain natural substance made by the body (adrenaline) from acting on the heart and blood vessels. This effect reduces your blood pressure, lowers your pulse (number of times the heart beats in 1 minute), and lessens strain on the heart.

Bystolic® (nebivolol) is a prescription medication approved to treat high blood pressure (known medically as hypertension). It can be used alone or in combination with other high blood pressure medications.

Bystolic (nebivolol), a new beta-blocker drug, has been approved by the Food and Drug Administration for the treatment of high blood pressure (hypertension). It joins the battle against hypertension that is fought by 72 million U.S. adults, mostly senior citizens. Recent studies show that about 65 percent of patients are failing to reduce their blood pressure to the acceptable range.

Hypertension can increase the risks for stroke, heart failure, heart attack, kidney failure, and death. A beta blocker, a well-established class of medications, reduces blood pressure by reducing the force with which the heart pumps.

Bystolic is the newest beta blocker approved for the treatment of hypertension in the U.S. and should prove useful due to its efficacy in a broad range of patients and its favorable side effect profile. These features will be attractive to both physicians and patients.

— Michael Weber, MD, Professor of Medicine at SUNY Downstate College of Medicine